Tonghua Dongbao Pharmaceutical Co., Ltd.

SHSE:600867 Stok Raporu

Piyasa değeri: CN¥16.7b

Tonghua Dongbao Pharmaceutical Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Tonghua Dongbao Pharmaceutical is forecast to grow earnings and revenue by 69.4% and 24.4% per annum respectively. EPS is expected to grow by 71.2% per annum. Return on equity is forecast to be 15.4% in 3 years.

Anahtar bilgiler

69.4%

Kazanç büyüme oranı

71.2%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi19.3%
Gelir büyüme oranı24.4%
Gelecekteki özkaynak getirisi15.4%
Analist kapsamı

Good

Son güncelleme04 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Pretty Healthy Balance Sheet

Oct 22
Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Pretty Healthy Balance Sheet

Tonghua Dongbao Pharmaceutical Co., Ltd.'s (SHSE:600867) Earnings Haven't Escaped The Attention Of Investors

Sep 30
Tonghua Dongbao Pharmaceutical Co., Ltd.'s (SHSE:600867) Earnings Haven't Escaped The Attention Of Investors

Some May Be Optimistic About Tonghua Dongbao Pharmaceutical's (SHSE:600867) Earnings

Sep 06
Some May Be Optimistic About Tonghua Dongbao Pharmaceutical's (SHSE:600867) Earnings

Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Analysts Just Slashed This Year's Estimates

Sep 05
Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Analysts Just Slashed This Year's Estimates

Calculating The Intrinsic Value Of Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867)

Aug 22
Calculating The Intrinsic Value Of Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867)

Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet

Jun 19
Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet

Improved Earnings Required Before Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Shares Find Their Feet

May 23
Improved Earnings Required Before Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Shares Find Their Feet

Kazanç ve Gelir Büyüme Tahminleri

SHSE:600867 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20263,9071,320N/A1,3175
12/31/20253,2351,055N/A1,0886
12/31/20242,14888N/A1,0133
9/30/20242,43234175614N/A
6/30/20242,449453227667N/A
3/31/20243,0011,132524858N/A
12/31/20233,0751,168513862N/A
9/30/20232,771939130528N/A
6/30/20232,757884213611N/A
3/31/20232,5561,001213666N/A
12/31/20222,7781,582370863N/A
9/30/20222,9121,6435651,185N/A
6/30/20222,9931,8204051,160N/A
3/31/20223,3321,8034761,163N/A
12/31/20213,2681,3085801,180N/A
9/30/20213,1621,2426541,147N/A
6/30/20213,0791,0608491,188N/A
3/31/20212,9969898541,206N/A
12/31/20202,8929307131,192N/A
9/30/20202,9068796581,054N/A
6/30/20202,8178207941,174N/A
3/31/20202,7818158561,119N/A
12/31/20192,7778118591,152N/A
9/30/20192,7418397871,109N/A
6/30/20192,6648344771,001N/A
3/31/20192,6888381391,099N/A
12/31/20182,693839104877N/A
9/30/20182,701876263938N/A
6/30/20182,827963N/A954N/A
3/31/20182,699900N/A898N/A
12/31/20172,545837N/A961N/A
9/30/20172,414789N/A900N/A
6/30/20172,332736N/A818N/A
3/31/20172,154690N/A840N/A
12/31/20162,040641N/A726N/A
9/30/20161,909604N/A687N/A
6/30/20161,779546N/A577N/A
3/31/20161,722533N/A359N/A
12/31/20151,669493N/A295N/A
9/30/20151,661450N/A248N/A
6/30/20151,576393N/A105N/A
3/31/20151,521321N/A158N/A
12/31/20141,451280N/A206N/A
9/30/20141,369215N/A142N/A
6/30/20141,308216N/A285N/A
3/31/20141,265198N/A305N/A
12/31/20131,204184N/A221N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 600867's forecast earnings growth (69.4% per year) is above the savings rate (2.9%).

Kazançlar ve Piyasa: 600867's earnings (69.4% per year) are forecast to grow faster than the CN market (25.8% per year).

Yüksek Büyüme Kazançları: 600867's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: 600867's revenue (24.4% per year) is forecast to grow faster than the CN market (14% per year).

Yüksek Büyüme Geliri: 600867's revenue (24.4% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 600867's Return on Equity is forecast to be low in 3 years time (15.4%).


Büyüyen şirketleri keşfedin